Imagine if Starpharma had used this same VC model back in 2012 to create a start-up company with AstraZeneca to drive the development of AZD0466.
Guess what the value of Starpharma’s 22.5% of the company would be today after 12 years. A big fat ZERO.
And they would never have received an initial licence fee and they wouldn’t have received a milestone payment when AZD0466 progressed into Phase One from pre-clinical.
What a great business model that would have been … for AstraZeneca.
- Forums
- ASX - By Stock
- SPL
- Big Pharma or Vulture Capitalists
Big Pharma or Vulture Capitalists, page-3
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.4¢ |
Change
-0.003(3.09%) |
Mkt cap ! $38.76M |
Open | High | Low | Value | Volume |
9.5¢ | 9.5¢ | 9.4¢ | $22.69K | 238.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 254380 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.4¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 254380 | 0.093 |
2 | 48260 | 0.092 |
3 | 66111 | 0.090 |
1 | 200000 | 0.088 |
2 | 147200 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.094 | 15000 | 1 |
0.095 | 320615 | 2 |
0.097 | 109947 | 2 |
0.098 | 65000 | 1 |
0.099 | 8000 | 1 |
Last trade - 10.16am 30/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online